Cytokinetics
Recent news from Cytokinetics summarized
Published in Hospital Business Week, December 3rd, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Cytokinetics.
Report 1: Cytokinetics, Incorporated (CYTK) announced results from a planned interim analysis following Stage 1 of a two-stage Phase II clinical trial of ispinesib administered as monotherapy in the treatment of patients with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC).
This clinical trial was conducted by the National Cancer Institute (NCI) under a collaboration with GlaxoSmithKline (GSK). A presentation entitled, "A Phase II Study of Ispinesib...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Allergy & Immunology
Medical-food products line developed for the dietary management of allergies - Alzheimer Disease
Panel convened by Alzheimer's Drug Discovery Foundation makes dementia therapy recommendations - Attention Deficit Hyperactivity Disorder
Daytrana provides individualized ADHD symptom management - Avian Influenza
Control measures fail to stop spread of new H5N1 virus - Awards
Cardinal Health recognizes outstanding suppliers - Awards
Internists take home several national awards at AAMC Annual Meeting - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
